Skip to main content
. 2021 Mar;13(3):1641–1651. doi: 10.21037/jtd-20-1662

Table 3. Impact of ICSs on cumulative number of acute exacerbations per patient.

Period (months) No ICSs ICSs Difference mean (95% CI) P value
N Mean ± SD N Mean ± SD
0–6 73 0.40±0.66 15 0.73±0.70 −0.33 (−0.71, 0.04) 0.08
6–12 72 0.33±0.58 14 0.36±0.63 −0.03 (−0.37, 0.32) 0.89
0–12 72 0.72±1.01 14 1.00±0.78 −0.28 (−0.85, 0.29) 0.33

ICS, inhaled corticosteroids; SD, standard deviation; CI, confidence interval.